We therefore hypothesized that induction of CCL2 by the interaction of infiltrated macrophages with surviving PCa cells during targeting AR via siAR might possibly obfuscate the benefits of anti-androgen/AR treatments, and may eventually facilitate the migration/invasiveness of the remaining PCa cells. The gene discussed is AR; the disease is posterior cortical atrophy.